Anubismed Cream
NDC Package 83021-551-50
Package Information
Anubismed (spf 50 broad spectrum protection fluid emulsion) cream is classified as a
- acidifying activity - [moa] (mechanism of action)
- allergens - [cs]
- anti-coagulant - [epc] (established pharmacologic class)
- ascorbic acid - [cs]
- calcium chelating activity - [moa] (mechanism of action)
- calculi dissolution agent - [epc] (established pharmacologic class)
- cell-mediated immunity - [pe] (physiologic effect)
- decreased coagulation factor activity - [pe] (physiologic effect)
- glycerol - [cs]
- increased histamine release - [pe] (physiologic effect)
- increased igg production - [pe] (physiologic effect)
- non-standardized chemical allergen - [epc] (established pharmacologic class)
- skin barrier activity - [pe] (physiologic effect)
- vitamin c - [epc] (established pharmacologic class)
Identification & Billing
Clinical Specifications
- .ALPHA.-TOCOPHEROL .006 g/50mL
- ANHYDROUS CITRIC ACID .00025 g/50mL
- ASCORBIC ACID .00025 g/50mL
- ASCORBYL PALMITATE .00125 g/50mL
- AVOBENZONE 1.8 g/50mL
- BEMOTRIZINOL 1.45 g/50mL
- BUTYLATED HYDROXYTOLUENE .0018 g/50mL
- BUTYLENE GLYCOL 2.5 g/50mL
- C20-22 ALCOHOLS .3375 g/50mL
- CARBOMER COPOLYMER TYPE A (ALLYL PENTAERYTHRITOL CROSSLINKED) .075 g/50mL
- CARBOMER HOMOPOLYMER, UNSPECIFIED TYPE .025 g/50mL
- CHLORPHENESIN .1 g/50mL
- DIMETHICONE 1.25 g/50mL
- FRAGRANCE 13576 .3 g/50mL
- GLYCERIN .005 g/50mL
- LINOLEIC ACID .49725 g/50mL
- LINOLENIC ACID .00275 g/50mL
- OCTINOXATE 3.5982 g/50mL
- OCTISALATE 1.8 g/50mL
- OCTOCRYLENE 1.8 g/50mL
- PHENOXYETHANOL .35 g/50mL
- POLY(METHYL METHACRYLATE 2.1 g/50mL
- 450000 MW) .14225 g/50mL
- POLYETHYLENE GLYCOL 400 2.5 g/50mL
- PROPYLENE GLYCOL .575 g/50mL
- SILICON DIOXIDE .425 g/50mL
- TITANIUM DIOXIDE .22 g/50mL
- TROMETHAMINE 27.55 mL/50mL
- WATER
- Acidifying Activity - [MoA] (Mechanism of Action)
- Allergens - [CS]
- Anti-coagulant - [EPC] (Established Pharmacologic Class)
- Ascorbic Acid - [CS]
- Calcium Chelating Activity - [MoA] (Mechanism of Action)
- Calculi Dissolution Agent - [EPC] (Established Pharmacologic Class)
- Cell-mediated Immunity - [PE] (Physiologic Effect)
- Decreased Coagulation Factor Activity - [PE] (Physiologic Effect)
- Glycerol - [CS]
- Increased Histamine Release - [PE] (Physiologic Effect)
- Increased IgG Production - [PE] (Physiologic Effect)
- Non-Standardized Chemical Allergen - [EPC] (Established Pharmacologic Class)
- Skin Barrier Activity - [PE] (Physiologic Effect)
- Vitamin C - [EPC] (Established Pharmacologic Class)
Regulatory & Marketing
Hierarchy Structure
- 83021 - Anubis Cosmetics Sl
- 83021-551 - Anubismed
- 83021-551-50 - 50 mL in 1 BOTTLE
- 83021-551 - Anubismed
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 83021-551-50 identifies a specific commercial package of 50 ml in 1 bottle of Anubismed, a human over the counter drug labeled by Anubis Cosmetics Sl. This cream is formulated for topical use and contains .alpha.-tocopherol; anhydrous citric acid; ascorbic acid; ascorbyl palmitate; avobenzone; bemotrizinol; butylated hydroxytoluene; butylene glycol; c20-22 alcohols; carbomer copolymer type a (allyl pentaerythritol crosslinked); carbomer homopolymer, unspecified type; chlorphenesin; dimethicone; fragrance 13576; glycerin; linoleic acid; linolenic acid; octinoxate; octisalate; octocrylene; phenoxyethanol; poly(methyl methacrylate; 450000 mw); polyethylene glycol 400; propylene glycol; silicon dioxide; titanium dioxide; tromethamine; water as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Anubis Cosmetics Sl on October 15, 2022.
How is this Anubis Cosmetics Sl product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 83021055150. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.